Identification of a Ten-Gene Signature of DNA Damage Response Pathways with Prognostic Value in Esophageal Squamous Cell Carcinoma

Figure 1

Performance of the DRGS in predicting OS in the training, testing, and validation sets. (a) Time-dependent ROC analyses at 1-, 3-, and 5-year survival rates of the DRGS in the meta-training set.(b), (c) KM analysis of the DRGS in the meta-training set. (d) Time-dependent ROC analyses at 1-, 3-, and 5-year survival rates of the DRGS in the meta-testing set. (d) KM analysis of the DRGS in the meta-testing set. KM analysis of the DRGS in (e) the meta-validation set and (f) the whole meta-data sets.

(a)

(b)

(c)

(d)

(e)

(f)